NCT05933330View on ClinicalTrials.gov

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

July 31, 2025

Conditions
Telangiectasia, Hereditary HemorrhagicIntracranial Arteriovenous Malformations
Interventions
OTHER

Brain MRI

All included patients receive an MRI of the brain

Trial Locations (1)

5000

Danish HHT-center. Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER